vorasidenib
servier
['vorasidenib', 'indigo']
 incredible news from #asco23! vorasidenib in the indigo phase 3 trial, transforming outcomes for idh-mutant grade 2 glioma patients. risk of progression or death reduced by 61%. a significant leap forward after two decades! #indigotrial #gliomatreatment
What’s happening in the treatment world of Cancer and Medicine